A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects with Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Trial Identifier: D6830C00001
Sponsor: AstraZeneca
NCTID:: NCT05110976
Start Date: December 2021
Primary Completion Date: August 2023
Study Completion Date: August 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translations
English Translation

Trial Locations